Christopher Hwang
Director Técnico/Científico/I+D en TRANSCENTA HOLDING LIMITED .
Cargos activos de Christopher Hwang
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TRANSCENTA HOLDING LIMITED | Director Técnico/Científico/I+D | 01/02/2019 | - |
Historial de carrera de Christopher Hwang
Antiguos cargos conocidos de Christopher Hwang.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SANOFI | Director/Miembro de la Junta | 01/01/2005 | 01/09/2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | 01/01/2005 | 01/02/2016 |
Formación de Christopher Hwang.
| Massachusetts Institute of Technology | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Islas Caimán | 2 |
| Francia | 2 |
Operativa
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| TRANSCENTA HOLDING LIMITED | Health Technology |
| SANOFI | Health Technology |
| Empresas privadas | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Hwang
- Experiencia
